- Current status
- AHSCT is a standard of care of RRMS
- Wykłady na kursie specjalizacyjnym – transplantologia
- AHSCT is better choice than DMDs in MS as a treatment of cases progressing after first line treatment – multicenter randomised trial.
- CPX-351 (Vyxeos) – new drug that improves treatment in older patients with secondary AML
Monthly Archives: November 2011
For those that saw that the name of my blog was changed from MD PhD to MD. I realized few weeks ago that the doctorate in Germany is not equal to Ph.D. – The doctorate in Poland is equal to … Continue reading